Dark

DVA
DaVita Inc.
stock NYSE

Market Open

Jun 30, 2026 2:24:03 PM EDT

222.42USD+1.238%(+2.72)344,481

210.11Bid 233.10Ask 22.99Spread

Pre-market

Jun 25, 2026 9:02:30 AM EDT

207.99USD-5.330%(-11.71)0

After-hours

Jun 29, 2026 4:05:30 PM EDT

219.70USD+0.039%(+0.08)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 27, 2022

04:06PM EST DaVita Inc. Schedules 4th Quarter 2021 Investor Conference Call PR Newswire

Jan 19, 2022

06:02AM EST Kidney Doctors, Transplant Providers Work with DaVita in New Government Program PR Newswire

Jan 18, 2022

06:09AM EST DaVita Announces Acquisition Of MedSleuth RTTNews

06:04AM EST DaVita Acquires MedSleuth; Terms Not Disclosed Benzinga

06:02AM EST DaVita Acquires MedSleuth, Deepens Efforts to Improve Transplant Experience PR Newswire

Jan 12, 2022

06:02AM EST DaVita Teammates Transformed Care for Thousands of Patients in 2021 PR Newswire

Jan 6, 2022

06:02AM EST DaVita Celebrates 10 Years of Kidney Smart(r) Educational Programming PR Newswire

Jan 5, 2022

09:39AM EST Truist Securities Maintains Hold on DaVita, Raises Price Target to $125 Benzinga

Dec 16, 2021

06:06AM EST DaVita Integrated Kidney Care Names David Roer Chief Medical Officer RTTNews

06:02AM EST DaVita Integrated Kidney Care Expands Clinical Leadership Team PR Newswire

Dec 9, 2021

06:04AM EST DaVita Says Its North American Operations Powered By 100% Renewable Energy RTTNews

06:02AM EST DaVita's North American Operations Now Powered by 100% Renewable Energy PR Newswire

Nov 30, 2021

06:02AM EST 15th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life PR Newswire

Nov 29, 2021

06:06AM EST DaVita Clinical Research Study Indicates Effectiveness Of mRNA COVID-19 Vaccines In Dialysis Patients Benzinga

06:01AM EST DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 PR Newswire

Nov 4, 2021

06:04AM EDT DaVita Clinical Research to Present New Findings at American Society of PR Newswire

Nov 1, 2021

06:02AM EDT The American Diabetes Association(r) and DaVita Raise Awareness about the Link PR Newswire

Oct 29, 2021

09:26AM EDT RBC Capital Maintains Sector Perform on DaVita, Lowers Price Target to $111 Benzinga

Oct 28, 2021

04:13PM EDT DaVita Q3 EPS $2.36 Vs. $1.28 Year Ago RTTNews

04:13PM EDT DaVita HealthCare Partners Inc. (DVA) released earnings for its third quarter that advanced from last year. RTTNews

04:09PM EDT DaVita Sees FY21 Adj. Operating Income $1.76B-$1.81B Benzinga

04:07PM EDT DaVita Q3 EPS $2.36 Beats $2.25 Estimate, Sales $2.94B Beat $2.93B Estimate Benzinga

04:06PM EDT DaVita Inc. 3rd Quarter 2021 Results PR Newswire

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 21, 2021

07:00AM EDT Renalytix plc (NASDAQ: RNLX),(LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,announces its results for the twelve months ended 30 June 2021. GlobeNewswire Inc

Oct 19, 2021

06:01AM EDT DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021 PR Newswire

06:01AM EDT DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call PR Newswire

Oct 13, 2021

01:38PM EDT Truist Securities Maintains Hold on DaVita, Lowers Price Target to $125 Benzinga

Oct 11, 2021

06:14AM EDT DaVita announced commitment to climate action goals with validation from the Science Based Targets initiative (SBTi). The organization has approved two goals supply chain partners representing 70% of emissions will set climate change goals by 202; reduce its carbon emissions by 50% by 2025. RTTNews

06:03AM EDT DaVita Climate Action Goals Approved By Science Based Target Initiative RTTNews

06:02AM EDT DaVita Climate Action Goals Approved by the Science Based Target Initiative PR Newswire

Sep 16, 2021

06:03AM EDT DaVita Kidney Care Names Tina Livaudais New Chief Nursing Officer RTTNews

06:02AM EDT DaVita Kidney Care Names New Chief Nursing Officer PR Newswire

Sep 10, 2021

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021 Benzinga

06:12AM EDT A Peek Into The Markets: US Stock Futures Up Ahead Of Producer Price Index; Crude Oil Rises Benzinga

05:13AM EDT Cowen & Co. Initiates Coverage On DaVita with Market Perform Rating, Announces Price Target of $145 Benzinga

Sep 9, 2021

04:03PM EDT DaVita Appoints Gregory Moore To Its Board Of Directors RTTNews

04:02PM EDT DaVita Announces Dr. Gregory Moore to Join its Board of Directors PR Newswire

08:00AM EDT Miromatrix Welcomes Dr. John Barry as Vice President of Research GlobeNewswire Inc

Aug 20, 2021

11:00AM EDT Looking into DaVita's Return on Capital Employed Benzinga

Aug 12, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021 Benzinga

06:21AM EDT Barclays Downgrades DaVita to Equal-Weight, Raises Price Target to $146 Benzinga

Aug 11, 2021

07:38AM EDT Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed Benzinga

07:00AM EDT Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO. GlobeNewswire Inc

Aug 3, 2021

05:38PM EDT DaVita: Q2 Earnings Insights Benzinga

04:21PM EDT DaVita HealthCare Partners Inc. (DVA) released earnings for its second quarter that climbed from last year. RTTNews

04:13PM EDT DaVita Raises FY21 EPS Guidance From $8.20-$9.00 To $8.80-$9.40 Vs. $8.57 Est. Benzinga

04:12PM EDT DaVita Q2 EPS $2.64 Beats $2.18 Estimate, Sales $2.92B Beat $2.87B Estimate Benzinga

04:08PM EDT DaVita Q2 EPS $2.64 Vs. $1.62 Year Ago RTTNews

04:06PM EDT DaVita Inc. 2nd Quarter 2021 Results PR Newswire

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Jul 30, 2021

06:44AM EDT DaVita's Debt Insights Benzinga

Jul 21, 2021

04:00AM EDT DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call PR Newswire

Jul 19, 2021

09:51AM EDT Deutsche Bank Maintains Buy on DaVita, Raises Price Target to $207 Benzinga

09:39AM EDT DaVita Shares Positive For Session; Hearing Deutsche Bank Sets Street High Price Target, Raises From $150 To $207 Benzinga

Jul 15, 2021

03:50PM EDT U.S. Justice Department Says DaVita, Former CEO Indicted In Ongoing Investigation Of Labor Market Collusion In Health Care Industry Benzinga

Jun 10, 2021

08:07AM EDT DaVita And The National Kidney Foundation Collaborate To Improve Health Equity In Kidney Transplantation RTTNews

08:04AM EDT DaVita and the National Kidney Foundation Join Forces to Improve Health Equity PR Newswire

Jun 2, 2021

06:09AM EDT DaVita Kidney Care Launches Virtual Support Groups Through DaVita Care Connect For Home Dialysis Patients RTTNews

06:07AM EDT Virtual Support Groups Create Community for DaVita Home Dialysis Patients PR Newswire

May 13, 2021

06:02AM EDT Extraordinary Nurses at DaVita Kidney Care Honored with DAISY Awards PR Newswire

May 10, 2021

11:26AM EDT Stocks That Hit 52-Week Highs On Monday Benzinga

06:02AM EDT DaVita Kidney Care Announces Expansion Of Its Home Kidney Care Program RTTNews

06:01AM EDT DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter PR Newswire

Apr 29, 2021

05:55PM EDT Thursday, dialysis service provider DaVita Inc. (DVA) on Thursday posted first-quarter net income of $237.4 million, lower than $240 million in the same period last year. On a per share basis, earnings rose to $2.09 from $1.89 a year ago. RTTNews

04:51PM EDT Recap: DaVita Q1 Earnings Benzinga

04:51PM EDT DaVita Sees FY 2021 Adj. Operating Income $1.75B-$1.875B Benzinga

04:37PM EDT DaVita Q1 EPS $2.09 Beats $1.80 Estimate, Sales $2.82B Inline Benzinga

04:11PM EDT DaVita Q1 EPS From Cont Ops $2.09, Up 15.5% From Last Year RTTNews

04:06PM EDT DaVita Inc. 1st Quarter 2021 Results PR Newswire

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 27, 2021

06:02AM EDT DaVita Solidifies Commitment to ESG, Sets 2025 Goals PR Newswire

Apr 22, 2021

04:06PM EDT DaVita Inc. Schedules 1st Quarter 2021 Investor Conference Call PR Newswire

Apr 12, 2021

10:01AM EDT DaVita Says Blue Cross And Blue Shield Of Minnesota Launches Program With Co's VillageHealth To Improve Care For Members With Kidney Disease Benzinga

10:01AM EDT Blue Cross and Blue Shield of Minnesota Launches Program with DaVita's PR Newswire

Mar 29, 2021

06:05AM EDT DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs PR Newswire

Mar 26, 2021

02:06PM EDT BofA Downgrades DaVita On Low Exposure to Volume Rebound Benzinga

10:23AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021 Benzinga

08:38AM EDT B of A Securities Downgrades DaVita to Underperform, Lowers Price Target to $118 Benzinga

Mar 25, 2021

11:02AM EDT DaVita Issues Statement On Government's Nationwide Program To Vaccinate Dialysis Patients (Full Statement) Benzinga

11:01AM EDT DaVita Statement on Government's Nationwide Program to Vaccinate Dialysis PR Newswire

Mar 23, 2021

08:03AM EDT DaVita Kidney Care Expands Use Of NxStage Home Hemodialysis Machines From Fresenius Medical Care RTTNews

08:01AM EDT DaVita Kidney Care Expands Use of NxStage Home Hemodialysis Machines from PR Newswire

Mar 9, 2021

03:00AM EST DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference PR Newswire

Mar 2, 2021

07:00AM EST Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (RenalytixAI or the Company), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter and six months ended December 31, 2020. GlobeNewswire Inc

Feb 24, 2021

06:01PM EST DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion PR Newswire

07:48AM EST DaVita Announces Add-On Offering Of $750 Mln Senior Notes RTTNews

07:45AM EST DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes PR Newswire

Feb 16, 2021

01:56PM EST DaVita Shares Spike Higher; Warren E. Buffett Reports A 33% Stake In Co Benzinga

Feb 11, 2021

04:47PM EST Recap: DaVita Q4 Earnings Benzinga

04:39PM EST DaVita HealthCare Partners Inc. (DVA) revealed earnings for fourth quarter that fell from the same period last year. RTTNews

04:09PM EST DaVita Q4 EPS From Cont Ops $1.67 Vs $1.86 Last Year RTTNews

04:08PM EST DaVita Sees FY21 Adj. EPS $7.75-$8.75 vs $8.16 Est. Benzinga

04:07PM EST DaVita Q4 EPS $1.67 Misses $1.87 Estimate, Sales $2.90B Miss $2.93B Estimate Benzinga

04:06PM EST DaVita Inc. 4th Quarter 2020 Results PR Newswire

03:51AM EST Earnings Scheduled For February 11, 2021 Benzinga

Feb 10, 2021

10:36AM EST DaVita's Earnings Outlook Benzinga

Feb 6, 2021

08:53PM EST DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc PR Newswire

Jan 29, 2021

05:49AM EST DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call PR Newswire

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

Jan 5, 2021

10:44AM EST DaVita shares were trading lower after Bank of America downgraded the stock from Buy to Neutral and announced a price target of $127 per share. Benzinga

10:11AM EST Benzinga's Top Upgrades, Downgrades For January 5, 2021 Benzinga

09:59AM EST A Look Into DaVita's Price Over Earnings Benzinga

08:00AM EST B of A Securities Downgrades DaVita to Neutral, Announces $127 Price Target Benzinga

06:00AM EST Early Risk Identification at Core of Innovative Kidney Care GlobeNewswire Inc

Dec 22, 2020

10:38AM EST P/E Ratio Insights for DaVita Benzinga

06:11AM EST DaVita Kidney Care Announces That More Than 100,000 DaVita Patients Have Received A Kidney Transplant Since 2000 RTTNews

06:07AM EST DaVita Celebrates 100,000 Patients Receiving Kidney Transplants PR Newswire

Nov 23, 2020

06:04AM EST 14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life PR Newswire

Nov 17, 2020

12:00PM EST Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios Benzinga

Nov 5, 2020

09:52AM EST 68 Stocks Trading Near 52-Week Highs Just After Open On Thursday, Nov. 5, 2020: Benzinga

Nov 4, 2020

10:09AM EST Stocks Trading Near 52-Week Highs Just After Open On Wednesday, Nov. 4, 2020 Include NICE, ETN, CDNS, CARR, HUM, ANTM, Others Benzinga

02:30AM EST DaVita Kidney Care Says Grateful That Californians Voted Down Proposition 23 RTTNews

02:14AM EST DaVita Responds to Proposition 23 in California PR Newswire

Oct 29, 2020

04:10PM EDT DaVita Raises FY20 Adj. EPS Guidance From $6.25-$6.75 To $7.35-$7.60 vs $6.85 Est., Narrows FY20 Sales Guidance From $11.5B-$11.7B To $11.5B-$11.6B vs $11.6B Est. Benzinga

04:07PM EDT DaVita HealthCare Partners Inc. (DVA) revealed a profit for its third quarter that climbed from the same period last year. RTTNews

04:03PM EDT DaVita Q3 Adj. EPS $1.80 Beats $1.44 Estimate, Sales $2.92B Miss $2.94B Estimate Benzinga

04:03PM EDT DaVita Q3 EPS $1.28 Vs. $0.95 Year Ago RTTNews

04:01PM EDT DaVita Inc. 3rd Quarter 2020 Results PR Newswire

01:31PM EDT Notable Earnings Watchlist For Thursday, Oct. 29, 2020 After Market Close: AAPL, MGM, X, PFPT, SHAK, ATVI, AMZN, MSI, MHK, TWTR, VRTX, WW, TEAM, SYK, SBUX, EMN, CHE, COLM, CENX, DECK, CAR, ATUS, ADM, AUY, DVA, GOOG, FTNT, FB Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 28, 2020

10:04AM EDT Earnings Outlook For DaVita Benzinga

Oct 22, 2020

09:04AM EDT DaVita Clinical Research to Present New Findings at American Society of PR Newswire

09:02AM EDT DavIta Clinical Research To Present New Findings At American Society Of Nephrology Kidney Week 2020 Benzinga

Oct 15, 2020

04:53PM EDT DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call PR Newswire

Sep 27, 2020

06:12PM EDT Notable Insider Buys Last Week: Snowflake, Broadcom And More Benzinga

Sep 17, 2020

06:04AM EDT DaVita Reports Final Results Of Self-Tender Offer RTTNews

06:00AM EDT DaVita Announces Final Results Of Self-Tender Offer PR Newswire

Sep 15, 2020

06:43AM EDT DaVita Announces Preliminary Results Of Self-Tender Offer For $1.0 Bln Common Stock RTTNews

06:30AM EDT DaVita Announces Preliminary Results of Self-Tender Offer PR Newswire

Sep 8, 2020

06:02AM EDT DaVita Announces Shawn Guertin To Join Board, Effective Sept. 15 RTTNews

06:01AM EDT DaVita Announces Shawn Guertin Will Join its Board of Directors PR Newswire

Aug 31, 2020

02:42PM EDT A Look At Berkshire Hathaway's Top 9 Holdings On Warren Buffett's 90th Birthday Benzinga

Aug 27, 2020

04:07PM EDT DaVita Opens Its Doors to Hurricane Laura Evacuees Needing Dialysis PR Newswire

Aug 20, 2020

06:30AM EDT DaVita Clinical Research To Conduct COVID-19 Studies In RTTNews

06:14AM EDT DaVita Clinical Research Begins Enrollment On Clinical Research Trials To Study How COVID-19 Affects Dialysis Patients RTTNews

06:12AM EDT DaVita Clinical Research Begins Enrollment In Trial Studying Study COVID-19 Impact On Dialysis Patients Benzinga

06:07AM EDT Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients PR Newswire

Aug 17, 2020

05:11AM EDT DaVita Inc. (DVA) has commenced a modified "Dutch auction" tender offer for shares of its common stock for an aggregate purchase price of up to $1.0 billion at a price per share of not less than $77.00 and not more than $88.00. The tender offer will expire on September 14, 2020. RTTNews

04:14AM EDT DaVita Commences Modified "Dutch Auction" Tender Offer For Shares For Purchase Price Of Up To $1.0 Bln RTTNews

04:00AM EDT DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common PR Newswire

Aug 13, 2020

04:08PM EDT Myriad Genetics Appoints Paul J. Diaz as President and Chief GlobeNewswire Inc

06:21AM EDT DaVita Expands Tuition And Support Program For Clinical Teammates To Advance Nursing Education RTTNews

06:17AM EDT DaVita Expands Initiative to Advance Nursing Education PR Newswire

Aug 11, 2020

04:42AM EDT DaVita Appoints Paula Price To Board, Effective Sept 1 RTTNews

04:31AM EDT DaVita Announces Paula A. Price to Join its Board of Directors PR Newswire

Aug 6, 2020

06:03PM EDT DaVita Reports Pricing Of $1.5 Bln Senior Notes Offering RTTNews

06:02PM EDT DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering PR Newswire

07:28AM EDT DaVita Inc. Begins Private Offering Of $1.5 Bln Of Senior Notes Due 2031 RTTNews

07:28AM EDT DaVita Inc. Announces Offering of $1.5 Billion Senior Notes PR Newswire

Jul 30, 2020

05:33PM EDT DaVita HealthCare Partners Inc. (DVA) announced a profit for its second quarter that climbed from last year. RTTNews

05:20PM EDT DaVita (DVA) said, for fiscal 2020, the company's current outlook for adjusted net income per share from continuing operations is $6.25 to $6.75, compared to prior guidance range of $5.75 to $6.25. Revenue is anticipated in a range of $11.50 billion to $11.70 billion. RTTNews

04:04PM EDT DaVita Q2 EPS $1.95 May Not Compare To $1.30 Estimate, Sales $2.88B Miss $2.93B Estimate Benzinga

04:03PM EDT DaVita Q2 EPS $1.62 Vs. $1.64 Year Ago RTTNews

04:02PM EDT DaVita Inc. 2nd Quarter 2020 Results PR Newswire

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga

Jul 15, 2020

04:01PM EDT DaVita Inc. Schedules 2nd Quarter 2020 Investor Conference Call PR Newswire

document.getElementById("h2Rsjq").onerror = function(){this.style.display='none';}; .dark-mode .Q5lLMr{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Q5lLMr{ color: #333333; background-color: white; border: 2px solid #333333; }DVADaVita Inc.stock NYSE

DVA
DaVita Inc.
stock NYSE